TFS Financial (TFSL) director receives 7,500 RSUs equity grant
Rhea-AI Filing Summary
TFS Financial Corporation director reported an equity award and updated holdings. On December 18, 2025, the reporting person received a grant of 7,500 restricted stock units (RSUs), each representing a contingent right to receive one share of TFS Financial Corporation common stock. These RSUs carry dividend equivalent rights, meaning they are entitled to cash payments equal to any cash dividends paid per share of common stock, and they fully vest on December 10, 2026.
Following this grant, the director reports beneficial ownership of 16,510 shares of common stock held directly, 40,000 shares held as trustee for a family trust, and 37,150 shares held as a trust beneficiary, along with the 7,500 RSUs reported as a derivative security.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did TFS Financial (TFSL) report in this filing?
The filing reports that a director of TFS Financial Corporation received a grant of 7,500 restricted stock units (RSUs) on December 18, 2025.
When do the 7,500 RSUs granted by TFS Financial (TFSL) vest?
The 7,500 RSUs granted to the director fully vest on December 10, 2026.
What rights do the TFS Financial (TFSL) RSUs provide to the director?
Each RSU represents a contingent right to receive one share of TFS Financial Corporation common stock and is entitled to dividend equivalent rights in the form of cash payments equal to any cash dividends paid per share.
How many TFS Financial (TFSL) shares does the director own directly after the transaction?
After the reported transaction, the director beneficially owns 16,510 shares of TFS Financial Corporation common stock directly.
What indirect holdings in TFS Financial (TFSL) does the director report?
The director reports 40,000 shares held as trustee for a family trust and 37,150 shares as a trust beneficiary, in addition to the direct holdings.
How are the 7,500 RSUs in this TFS Financial (TFSL) filing classified?
The 7,500 RSUs are reported as a derivative security that is exercisable into common stock, with 7,500 derivative securities beneficially owned following the transaction.